AID Logo

Directory >> H. Nina Kim, MD, MSc


Contact Information

H. Nina Kim, MD, MSc

  • Associate Professor, Allergy and Infectious Diseases
    Department of Medicine, University of Washington
  • Adjunct Associate Professor
    Department of Global Health, University of Washington
  • Academic Director, HIV/STI Graduate Certificate Program

Dr. Kim works as a clinician-educator at the Harborview (HMC) Hepatitis & Liver Clinic and at the HMC Madison (HIV) Clinic. She is the Director of the Madison HIV/Hepatitis Coinfection Clinic. She serves as Associate Editor for Hepatitis C Online, a CDC-sponsored web-based curriculum and directs Global Health 573 , a UW graduate-level course entitled "Clinical Management of HIV," which is offered to both local and international students. She is the academic director of the UW HIV/STI Graduate Certificate program.

Dr. Kim is the lead investigator for the Liver Disease section of the UW Center for AIDS Research Clinical Epidemiology & Health Services Research Core. Her research has included work on chronic hepatitis B and hepatitis B vaccination in HIV-infected patients. Her current research is focused on clinical predictors of liver disease progression in HIV-infected patients.

Selected Publications

Kim HN, Nance R, Van Rompaey S, Delaney JC, Crane HM, et al. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis. J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):437-43.
PubMed PMID: 26990826

Kim HN, Rodriguez CV, Van Rompaey S, et. al. “Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort.” J Acquir Immune Defic Syndr. 2014;66:96-101.
PubMed Abstract

Chung MH, Severynen AO, Hals MP, Harrington RD, Spach DH, Kim HN. Offering an American graduate medical HIV course to health care workers in resource-limited settings via the internet." PLoS One. 2012; 7(12): e52663.
PubMed Abstract

Kim HN, Scott J, Cent A, Cook L, Ashley-Morrow R, Richardson B, et al. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. J Viral Hep. 2011; 18(10): e447-52.
PubMed Abstract

Kim HN, Harrington RD, Crane HM, Dhanireddy S, Dellit TH, Spach DH. Hepatitis B vaccination in HIV-infected adults: current guidelines and practical considerations. Int J STD AIDS. 2009; 20(9): 595-600.
PubMed Abstract

Kim HN, Harrington RD, VanRompaey S, Kitahata MM. Independent clinical predictors of hepatitis B vaccination in HIV-infected patients. Int J STDS AIDS. 2008; 19(9): 600-4.
PubMed Abstract

Kim HN, Harrington RD, Shuhart MC, et al. Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy. AIDS Patient Care STDS. 2007; 21(10): 718-23.
PubMed Abstract

to top